Endo shareholders elect all six director nominees and approve say-on-pay at 2025 annual meeting

Endo LP

All six director nominees elected with >99% approval among votes cast; broker non-votes of ~16M shares.
Say-on-pay passed with 54,275,482 for vs 15,191 against; board set future advisory votes on an annual basis.
PricewaterhouseCoopers ratified as auditor for FY2025 with 70,338,933 votes for, 5,746 against.
No other matters were brought before the meeting.

item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.